Crossref
‘CellPh-Linker Conjugation’: An engineering-free Fab-site selective ADC conjugation technology
European Journal of Cancer · 2026-11 · 248 · 117484
DOI: 10.1016/j.ejca.2026.117484 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von J. Ha und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ha, J., Choi, E., Ryu, S., Lee, J., Park, S., Kim, M., Lim, S., Kim, S., Jeong, D., Kang, H., Kim, J., & Lee, C. (2026). ‘CellPh-Linker Conjugation’: An engineering-free Fab-site selective ADC conjugation technology. European Journal of Cancer, 248, 117484. https://doi.org/10.1016/j.ejca.2026.117484
Vancouver
Ha J, Choi E, Ryu S, Lee J, Park S, Kim M, et al. ‘CellPh-Linker Conjugation’: An engineering-free Fab-site selective ADC conjugation technology. European Journal of Cancer. 2026;248:117484. doi:10.1016/j.ejca.2026.117484
BibTeX
@article{Ha2026,
author = {Ha, J. and Choi, E. and Ryu, S. and Lee, J. and Park, S. and Kim, M.J. and Lim, S. and Kim, S.H. and Jeong, D.W. and Kang, H.J. and Kim, J. and Lee, C.S.},
title = {‘CellPh-Linker Conjugation’: An engineering-free Fab-site selective ADC conjugation technology},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117484},
doi = {10.1016/j.ejca.2026.117484}
}
EUVIMED